Skip to main content

Table 1 PTEN status in endometrial cancer cell lines

From: Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells

 

PTEN status

Histological subtypes

Cell lines

Codon

Mutation

Predictive effect

Endometrioid adenocacioma

HEC-6

INTRON 4 (+2)

T TO C

Splice donor

 

289

1bp (A) del

Frameshift

HEC-59

41

TAC to TAC

Tyr (Y) to His (H)

 

233

CGA to TGA

Stop

 

246

CCG to CTG

Pro (P) to Leu (L)

 

267

1bp (A) del

Frameshift

HEC-88

130

CGA to GGA

Arg (R) to Gly (G)

 

173

CGC to TGC

Arg (R) to Cys (C)

 

310

GAT to TAT

Asp (D) to Tyr (Y)

 

341

TTT to TGT

Phe (F) to Cys (C)

HEC-108

6

2bp (AA) del

Frameshift

 

289

1bp (A) del

Frameshift

HEC-116

Intron 2 (-1)

G to A

Splice acceptor

 

173

CGC to TGC

Arg (R) to Cys (C)

 

233

CGA to TGA

Stop

HEC-151

33

3bp (ATT) del

In frame deletion

 

76

2bp (AT) del

Frameshift

HHUA

164

1bp (A) del

Frameshift

 

289

1bp (A) del

Frameshift

AN3CA

130

1bp (G) del

Nonsence

Ishikawa3-H-12

289

1bp (A) del

Frameshift

 

317-318

4bp (ACTT) del

Frameshift

RL95-2

322

1bp (A) del and 1bp (A) ins

Frameshift

HEC-251

10

AGC to AAC

Ser (S) to Asn (N)

HEC-265

319

1bp (A) ins

Frameshift

KLE

WT

None

 

HEC-1B

WT

None

 

HEC-50B

WT

None

 

Serous adenocarcinoma

HEC-180

WT

None

Â